Anebulo Pharmaceuticals (ANEB) Stock Chart & Stock Price History $1.72 +0.07 (+4.50%) As of 10:16 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Anebulo Pharmaceuticals Stock Price Performance The Anebulo Pharmaceuticals (ANEB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 35.38%, with a year-to-date return of 2.32%. In the past month, the stock has increased 59.17%, reflecting recent market activity. As of the latest close, Anebulo Pharmaceuticals traded at $1.65 with a market cap of $69.02 million and volume of 75,188 shares. Receive ANEB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Anebulo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.82%1 Month Performance+59.17%3 Month Performance+75.41%Year-To-Date Performance+2.32%1 Year Performance-35.38% ANEB Stock Chart for Tuesday, July, 8, 2025 ANEB Chart by TradingView Anebulo Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/07/2025$1.71$1.65-3.52%$2.00$1.5775,188 shs$69.02 million07/04/2025$1.71$1.71$1.81$1.6810,666 shs$70.05 million07/03/2025$1.81$1.71-5.80%$1.81$1.6810,666 shs$70.04 million07/02/2025$1.75$1.81+3.43%$2.46$1.3986,314 shs$74.36 million07/01/2025$1.44$1.75+21.53%$2.17$1.36109,127 shs$71.89 million06/30/2025$1.46$1.44-1.37%$1.49$1.442,481 shs$59.16 million06/27/2025$1.42$1.46+2.82%$1.47$1.3724,507 shs$59.98 million06/26/2025$1.47$1.42-3.40%$1.44$1.315,095 shs$58.33 million06/25/2025$1.50$1.47-2.00%$1.48$1.411,574 shs$60.40 million06/24/2025$1.52$1.50-1.32%$1.56$1.482,787 shs$61.62 million Get the Latest News and Ratings for ANEB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Anebulo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 06/23/2025$1.54$1.52-1.30%$1.60$1.458,234 shs$62.44 million06/20/2025$1.55$1.54-0.65%$1.59$1.438,275 shs$63.27 million06/19/2025$1.55$1.55$1.59$1.327,800 shs$63.67 million06/18/2025$1.47$1.55+5.44%$1.59$1.327,800 shs$63.67 million06/17/2025$1.58$1.47-6.96%$1.69$1.4314,195 shs$60.40 million06/16/2025$1.39$1.58+13.67%$1.62$1.4515,242 shs$64.91 million06/13/2025$1.27$1.39+9.45%$1.45$1.228,824 shs$57.11 million06/12/2025$1.16$1.27+9.48%$1.35$1.189,666 shs$52.18 million06/11/2025$1.09$1.16+6.42%$1.18$1.103,205 shs$47.66 million06/10/2025$1.10$1.09-0.91%$1.18$1.066,220 shs$44.78 million06/09/2025$1.08$1.10+1.85%$1.11$1.055,608 shs$45.19 million Related Companies Prima BioMed Stock Price Chart Aurora Cannabis Stock Price Chart Neurogene Stock Price Chart Tvardi Therapeutics Stock Price Chart biote Stock Price Chart Acelyrin Stock Price Chart Semper Paratus Acquisition Stock Price Chart Canopy Growth Stock Price Chart ProQR Therapeutics Stock Price Chart Nanobiotix Stock Price Chart Receive ANEB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Anebulo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ANEB) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anebulo Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anebulo Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ANEB Stock Alerts